Optimizing Pre-Clinical Drug Safety Conference
Conference - Boston, MA, United States of America
Determining the safety and toxicity of a drug is an extremely important and complicated task. While in the early discovery phases for a new drug, testing the drug’s toxicology has become an integral party of early research. Both ADME (Absorption, Distribution, Metabolism, Excretion) and toxicology testing have made impacts in the world of pre-clinical drug safety and have become one of the most significant research processes related to new drug discovery.
marcus evans invites VPs, Heads, Directors, Senior Managers, and Scientists with responsibilities in:
-- Toxicology
-- Exploratory Toxicology
-- Investigative Toxicology
-- Regulatory Toxicology
-- Pre-Clinical Safety
-- Pre-Clinical Safety Assessment
(Courtesy of bostonparkplaza.com)
Tue, May 21, 2013 - Wed, May 22, 2013
Omni Parker House Hotel, Boston, MA, United States of America
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
